Labshake search
Citations for Tocris :
151 - 200 of 1925 citations for Ethyl 4 acetyl 1 cyclopropyl 2 5 dimethyl 1H pyrrole 3 carboxylate since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... in combination with potassium channel blocker 4-aminopyridine (4-AP, 1 mM, Tocris) to facilitate transmitter release at monosynaptic connections from RSC to ChC and recorded the PSP amplitudes (Figure 1H) ...
-
bioRxiv - Neuroscience 2024Quote: The AMPA receptor antagonist 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione (DNQX disodium salt; Tocris) or 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX disodium salt ...
-
bioRxiv - Neuroscience 2021Quote: ... and 4-AP (1 mM, Tocris Bioscience), as was done previously (Carta et al. ...
-
bioRxiv - Developmental Biology 2023Quote: ... 1 µM 4-OH-TMX (Tocris Bioscience) was added to sustain knockout efficiency ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50 µM D-(-)-2-amino-5-phosphonopentanoic acid (AP5, Tocris Bioscience) were added to the bath to block glutamatergic currents ...
-
bioRxiv - Immunology 2021Quote: ... and 5 ng/ml IL-2 (carrier-free; Tocris R&D Systems) added with cells ...
-
bioRxiv - Neuroscience 2022Quote: ... D-2-Amino-5-phosphonopentanoic acid (D-AP5, 25 μM; Tocris #0106). These were stored as stock aliquots and diluted in fresh aCSF to their final concentration the day of recording ...
-
bioRxiv - Neuroscience 2024Quote: ... and D-2-amino-5-posphonopentanoic acid (APV, 100 μM; Tocris, US) at a holding potential−70 mV (n = 12).
-
bioRxiv - Neuroscience 2024Quote: ... and 50 µM 2-amino-5-phosphonopentanoic acid (D-AP5, Tocris Bioscience) were present in the extracellular solutions to isolate spontaneous IPSCs ...
-
bioRxiv - Developmental Biology 2023Quote: ... N6,2’-O-Dibutyryladenosine 3’,5’-cyclic monophosphate sodium salt (DB-cAMP, TOCRIS Cat. No.: 1141), 8-(4-Chlorophenylthio)-N6-phenyladenosine-3’,5’-cyclic monophosphate sodium salt (8C6P-cAMP ...
-
bioRxiv - Neuroscience 2024Quote: ... 10 μM DL-AP4 (DL-2-amino-4-phosphonobutyric acid, Tocris Bioscience, #0101), 10 μM (±)-CPP (3-[(R)-2-carboxypiperazin-4-yl]-propyl-1-phosphonic acid ...
-
bioRxiv - Microbiology 2022Quote: NADA (3-[(7-Nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-alanine hydrochloride) was synthesized by Tocris following the published protocol (31) ...
-
bioRxiv - Cell Biology 2022Quote: At day 0 cells were treated with 5 nM 4-Hydroxytamoxifen (+HOT) (Tocris, 3412) or with vehicle (-HOT ...
-
bioRxiv - Neuroscience 2024Quote: ... 2 mM stock made in water) and 2 mM 4-Methoxy-7-nitroindolinyl-caged-L-glutamate (MNI caged glutamate) (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2020Quote: ... 6,7-dinitroquinoxaline-2,3(1H,4H)-dione disodium salt (DNQX; No. 2312) was obtained from Tocris.
-
bioRxiv - Cell Biology 2021Quote: ... Calcium-like peptide 2 (CALP2) and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-7) were obtained from Tocris (Minneapolis, MN). CaM kinase II and calcineurin inhibitors ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 μM DMH-1 (Tocris) for 6 d ...
-
bioRxiv - Neuroscience 2024Quote: ... and 1 mM 4-AP (Tocris Biosciences, #0940). Neurons were clamped at −20 mV for 200 ms ...
-
bioRxiv - Neuroscience 2024Quote: ... or 4-DAMP (10 mg kg−1; Tocris) and controls treated with equivalent volume of vehicle ...
-
bioRxiv - Cancer Biology 2023Quote: ... N-(1,3,4-thiadiazol-2-yl) pyridine-3-carboxamide dihydrochloride (TGN-020, Tocris Cat No 5425) was used in vitro at 10-100 μM ...
-
bioRxiv - Developmental Biology 2021Quote: ... From passage 3 cells were grown NMP differentiation medium supplemented with 5 μM Y-27632 (Tocris). Human iPSCs were found to detach more readily than hESCs ...
-
bioRxiv - Genomics 2021Quote: ... neurons were made quiescent for 2 hours with 100 μM D-2- amino-5-phosphonopentanoic acid (D-AP5; Tocris #0106) and 1 μM tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2023Quote: ... and 100 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-APV, Tocris, 0106) to block glutamatergic inputs ...
-
bioRxiv - Neuroscience 2023Quote: ... CNQX and D(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) were from Tocris Biosciences ...
-
bioRxiv - Neuroscience 2023Quote: ... DL-2- amino-5-phosphono-pentanoic acid (AP5; 50 µM; Tocris, Item# 0105), 4-Aminopyridine (4- AP ...
-
bioRxiv - Neuroscience 2023Quote: ... D-2-amino-5-phosphonopentanoate (D-AP5, Tocris, Ellisville, MO, Cat. No. 0106 ), and Dizocilpine ((+)-MK801 ...
-
bioRxiv - Neuroscience 2023Quote: ... NMDAR antagonist D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV 50µM, Tocris-0106) and tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2021Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 μM, Tocris Bioscience, Bristol, UK) were diluted to the appropriate concentration from stock solutions and added to the bath through the perfusion system for 10 minutes before recordings ...
-
bioRxiv - Neuroscience 2021Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 μM, Tocris Bioscience, Bristol, UK) were diluted to the appropriate concentration from stock solutions and added to the Ames medium before recordings.
-
bioRxiv - Neuroscience 2023Quote: ... and 2 mM 4-Methoxy-7-nitroindolinyl-caged-L-glutamate (MNI caged glutamate) (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2023Quote: ... followed by seven days medium d3–9 (Medium d1-2 with 3 µM CHIR99021 [Tocris, 4423]), one day of medium d10 (Medium d3–9 with 200 µM ascorbic acid [Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2024Quote: Glymphatic inhibition was achieved using TGN-020 (N-1,3,4-thiadiazol-2-yl-3-pyridinecarboxamide, Tocris Bioscience). Mice were treated i.p ...
-
bioRxiv - Molecular Biology 2022Quote: Parental A549 cells were fixed with 4% paraformaldehyde following 3-hour treatment with poly I:C (2.0 μg/mL, Tocris), LPS (1.0 μg/mL ...
-
bioRxiv - Bioengineering 2024Quote: ... Verteporfin (1 or 2 μg/ml, Tocris) was added to the culture media 24 hours post seeding ...
-
bioRxiv - Cancer Biology 2024Quote: ... mice were randomized into groups and treated daily (5 days on, 2 days off) with 1mg/kg SB290157 trifluoroacetate (Tocris, 6860/5) intra-peritoneally ...
-
bioRxiv - Neuroscience 2020Quote: ... DL-2-Amino-5-phosphonopentanoic acid sodium salt (AP5, Cat. No. 3693, Tocris, UK), (-)-Bicuculline methochloride (Cat ...
-
bioRxiv - Neuroscience 2022Quote: ... and L-2-amino-5-phosphonopentanoic acid (APV, an NMDA receptor blocker) from Tocris. APV ...
-
bioRxiv - Neuroscience 2023Quote: ... and 50 μM 2-amino-5-phosphonopentanoic acid (D-AP5; Tocris Bioscience, Cambridge, UK) to avoid spontaneous network activation ...
-
bioRxiv - Neuroscience 2022Quote: ... and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5, TOCRIS bioscience #0105). NH4Cl perfusions were done with 50 mM NH4Cl in substitution of 50 mM NaCl (pH 7.4) ...
-
bioRxiv - Neuroscience 2024Quote: ... and 30 μm d-2-amino-5-phosphonovalerate (d-AP5) (NMDA receptor antagonist, Tocris).
-
bioRxiv - Cell Biology 2023Quote: ... the samples were blocked for 2 hours in HBSS with 4% BSA (Tocris BioScience, #5217). Incubation with primary antibody rabbit anti progesterone receptor (1:500 in 4% BSA ...
-
bioRxiv - Cell Biology 2024Quote: The PM fluidity of mammalian cells was measured using 3-((3-((9-(Diethylamino)-5-oxo-5H-benzo[a]phenoxazin-2-yl)oxy)propyl)(dodecyl)(methyl)ammonium)propane-1-sulfonate (NR12S; Tocris Bioscience Cat. No. 7509) using a method as exactly mentioned in Wendy S ...
-
bioRxiv - Neuroscience 2023Quote: ... raCSF contained [R-(R*,S*)]-5-(6,8-Dihydro-8-oxofuro[3,4-e]-1,3-benzodioxol-6-yl)-5,6,7,8-tetrahydro-6,6-dimethyl-1,3-dioxolo[4,5-g]isoquinolinium chloride (bicuculline methochloride, 10 μM dissolved in H2O; Tocris Bioscience). The following compounds were added to raCSF as indicated in the Results section ...
-
bioRxiv - Neuroscience 2021Quote: ... 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5, 0106, Tocris Bioscience, UK), and 10 μM of SR95531 (SR ...
-
HOIL-1L deficiency induces cell cycle alteration which causes immaturity of myocyte and fibrogenesisbioRxiv - Cell Biology 2023Quote: ... the medium was replaced with differentiation medium containing 5 μM IWP-2 (TOCRIS, Cat.# 3533), a Wnt inhibitor ...
-
bioRxiv - Neuroscience 2024Quote: ... BIBP-3226 (Y1 receptor antagonist, 1-2 μM), and BIIE-0246 (Y2 receptor antagonist, 1-2 μM) were obtained from Tocris.
-
bioRxiv - Neuroscience 2021Quote: ... 6R)-4-Amino-2-oxabicyclo [3.1.0] hexane-4,6-dicarboxylic acid disodium salt (LY379268, 100 µM, Tocris); calmidazolium chloride (CMZ ...
-
bioRxiv - Neuroscience 2024Quote: ... The following competitive antagonists were employed for microscopical experiments: trans-2-Carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline (L-689-560; Tocris); 7-Chloro-4-hydroxy-3-(3-phenoxy)phenyl-2(1H)-quinolinone (L-701-324 ...
-
bioRxiv - Molecular Biology 2024Quote: ... Ogt deletion was induced by exposing Ogt iKO mESC to 1 μM 4-hydroxytamoxifen (4-OHT) (TOCRIS, 3412). At the time points used in this study (6 days after 4-OHT treatment) ...
-
bioRxiv - Cell Biology 2024Quote: ... and Protein Phosphatase 1 inhibitor: Tautomycetin (Tocris Bioscience; 2305, 1 or 5 μΜ).